Anna Wołoszyn‐Durkiewicz

Combined therapy with <scp>CD4</scp> ⁺ <scp>CD25highCD127</scp> ⁻ T regulatory cells and <scp>anti‐CD20</scp> antibody in recent‐onset type 1 diabetes is superior to monotherapy: Randomized phase I/ <scp>II</scp> trial

Maciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz‐Grześ et al. · Diabetes Obesity and Metabolism · 2022 · 47 citations

Diabetic ketoacidosis incidence among children with new‐onset type 1 diabetes in Poland and its association with <scp>COVID</scp> ‐19 outbreak—Two‐year cross‐sectional national observation by <scp>PolPeDiab</scp> Study Group

Iwona Pietrzak, Arkadiusz Michalak, Sebastian Seget et al. · Pediatric Diabetes · 2022 · 18 citations · Full text

Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy

Mateusz Gliwiński, Dorota Iwaszkiewicz‐Grześ, Anna Wołoszyn‐Durkiewicz et al. · BMJ Open Diabetes Research & Care · 2020 · 16 citations · Full text

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration

Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz‐Grześ et al. · International Immunopharmacology · 2024 · 11 citations